Hearings to conclude Tuesday into whether ‘significant safety issues’ including reports of loss of sense of smell are cause for greater regulation of industry
Sceptics consider homeopathy a joke, a bogus science that belongs in a punchline, not a pharmacy – but US government regulators are suddenly taking it seriously.
The US Food and Drug Administration (FDA) is holding public hearings this week to explore whether it should toughen oversight of what has a become a controversial, billion-dollar branch of the healthcare industry.
Continue reading...
No comments:
Post a Comment